$60,000 of HEALTHPEAK PROPERTIES INC. FKA PHYSICIANS REALTY TRUST lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"monitor legislation affecting real estate investment trusts oppose legislation prohibiting REITs ownership of healthcare property; monitor BioSecure legislation oppose adoption of Corporate SALT provisions monitor legislation affecting site neutral cuts in Medicare"
You can find more data on corporate lobbying on Quiver Quantitative.
DOC Insider Trading Activity
DOC insiders have traded $DOC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DOC stock by insiders over the last 6 months:
- SCOTT R BOHN (CDO and Head of Lab) sold 10,989 shares for an estimated $213,740
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
DOC Hedge Fund Activity
We have seen 315 institutional investors add shares of DOC stock to their portfolio, and 399 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 30,192,317 shares (+inf%) to their portfolio in Q2 2026, for an estimated $646,115,583
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 11,940,893 shares (+inf%) to their portfolio in Q2 2026, for an estimated $255,535,110
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 6,187,772 shares (+20832.8%) to their portfolio in Q2 2026, for an estimated $132,418,320
- INVESCO LTD. removed 5,659,477 shares (-23.4%) from their portfolio in Q2 2026, for an estimated $121,112,807
- CENTERSQUARE INVESTMENT MANAGEMENT LLC removed 5,040,040 shares (-96.4%) from their portfolio in Q2 2026, for an estimated $107,856,856
- ALYESKA INVESTMENT GROUP, L.P. removed 4,640,803 shares (-82.6%) from their portfolio in Q2 2026, for an estimated $99,313,184
- GOLDMAN SACHS GROUP INC added 4,285,770 shares (+59.2%) to their portfolio in Q2 2026, for an estimated $91,715,478
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
DOC Analyst Ratings
Wall Street analysts have issued reports on $DOC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 05/22/2026
To track analyst ratings and price targets for DOC, check out Quiver Quantitative's $DOC forecast page.
DOC Price Targets
Multiple analysts have issued price targets for $DOC recently. We have seen 11 analysts offer price targets for $DOC in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- An analyst from UBS set a target price of $21.5 on 07/08/2026
- Richard Hightower from Barclays set a target price of $23.0 on 07/07/2026
- Vikram Malhotra from Mizuho set a target price of $24.0 on 07/06/2026
- Michael Mueller from JP Morgan set a target price of $21.0 on 06/24/2026
- Juan Sanabria from BMO Capital set a target price of $24.0 on 06/15/2026
- Richard Hill from Morgan Stanley set a target price of $22.0 on 06/11/2026
- John Kilichowski from Wells Fargo set a target price of $20.0 on 06/01/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
